DURHAM, N.C.--(BUSINESS WIRE)--Patheon,
a leading global provider of high-quality drug development and delivery
solutions to the pharmaceutical and biopharma industries, has hired
Andrew G. Long as senior vice president and global business controller.
Long will report to Stuart Grant, chief financial officer for Patheon,
and will be based at the company’s headquarters in Durham, N.C.
Long will focus on Patheon’s financial planning and performance
management tools and processes, in support of the company’s position as
a category leader in the pharma services industry.
He brings more than 25 years of experience to Patheon. He most recently
served as vice president, global finance of the Fisher Scientific Group
for Thermo Fisher Scientific, a biotechnology product development
company, where he was responsible for global financial planning and
analysis, controllership, mergers and acquisitions and strategic
“Andy is a great addition to our organization, said Grant. “He is a
seasoned professional with vast experience in all aspects of finance. We
will benefit from his experience as we advance our business strategy.”
Prior to joining Thermo Fisher, Long was vice president, worldwide
finance and supply chain management at Cambrex Corporation, responsible
for global financial planning, reporting and analysis for a division
with 14 manufacturing and distribution sites across 10 countries.
Previously, Long served in a number of roles of increasing
responsibility for companies including Eaton Corporation, Emerson
Electric and Abbott Laboratories.
“I am very pleased to join Patheon,” said Long. “The company is widely
recognized as a market leader with a solid growth profile.”
Long holds a Bachelor of Science from Indiana University and a Master of
Business Administration from the Kellogg Graduate School of Business,
Patheon is a leading global provider of pharmaceutical development and
manufacturing services. With approximately 8,700 employees worldwide,
Patheon provides a comprehensive, integrated and highly customizable set
of solutions to help customers of all sizes satisfy complex development
and manufacturing needs at any stage of the pharmaceutical development